Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04714398 · ClinicalTrials.gov registry record · NA

SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management

A NA study of Hypertension, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
425
Enrollment target
1
Study location

NCT04714398: Completed NA study of Hypertension, sponsored by University of Pennsylvania.

NCT04714398 is a NA study of Hypertension that has completed, run by University of Pennsylvania. The registered enrollment target is 425 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04714398, a NA study of Hypertension, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
425 participants
Enrollment target
1
Study location

Study Summary

A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).

Conditions Studied

Interventions

  • BEHAVIORAL Opt-In Recruitment
  • BEHAVIORAL Opt-Out Recruitment

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 425 participants
Start Date 2021-02-26
Est. Completion 2022-08-26
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04714398

The ClinicalTrials.gov registry entry for NCT04714398 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 425 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Opt-In Recruitment is the first listed.

NCT04714398 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04714398 about?

NCT04714398 is a clinical study titled "SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management". A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).

What is the current status of trial NCT04714398?

This trial is currently completed. It is a NA study. The enrollment target is 425 participants. The study started on 2021-02-26. Estimated completion is 2022-08-26.

What conditions does trial NCT04714398 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT04714398?

The interventions under investigation include: Opt-In Recruitment (BEHAVIORAL), Opt-Out Recruitment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04714398?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04714398 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.